Discussion on diagnosis and treatment of hepatobiliary malignancies during the outbreak of novel coronavirus pneumonia
10.3760/cma.j.cn112152-20200227-00137
- VernacularTitle: 新型冠状病毒肺炎疫情期间肝胆系统恶性肿瘤的诊疗策略探讨
- Author:
Fan WU
1
;
Yan SONG
1
;
Huiying ZENG
1
;
Feng YE
1
;
Weiqi RONG
1
;
Liming WANG
1
;
Jianxiong WU
1
Author Information
1. Department of Hepatobiliary Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
- Publication Type:Journal Article
- Keywords:
COVID-19;
Hepatobiliary system;
Neoplasms;
Diagnosis and treatment
- From:
Chinese Journal of Oncology
2020;42(0):E004-E004
- CountryChina
- Language:Chinese
-
Abstract:
From December 2019, the new coronavirus pneumonia (COVID-19) broke out in Wuhan, Hubei, and spread rapidly to the nationwide. On January 20, 2020, the National Health Committee classified COVID-19 pneumonia as one of B class infectious diseases and treated it as class A infectious disease. During the epidemic period, the routine diagnosis and treatment of tumor patients was affected with varying degrees. In this special period, we performed the superiority of the multi-disciplinary team of diagnosis and treatment, achieved accurate diagnosis and treatment of patients with hepatobiliary malignant tumors, provided support for these patients with limited medical resources, and helped them to survive during the epidemic period.On the basis of fully understanding the new coronavirus pneumonia, the treatment strategy should be changed timely during the epidemic, and more appropriate treatment methods should be adopted to minimize the adverse effect of the epidemic on tumor treatment.
